# First Time in Man Trial for Friulimicin B

> **NCT00492271** · PHASE1 · TERMINATED · sponsor: **MerLion Pharmaceuticals GmbH** · enrollment: 31 (actual)

## Conditions studied

- Community Acquired Pneumonia
- Staphylococcal Skin Infections

## Interventions

- **DRUG:** Friulimicin B

## Key facts

- **NCT ID:** NCT00492271
- **Lead sponsor:** MerLion Pharmaceuticals GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-06
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 31 (ACTUAL)
- **Why stopped:** Unfavourable Pharmakokinetics
- **Last updated:** 2008-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00492271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00492271, "First Time in Man Trial for Friulimicin B". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00492271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*